CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.24% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
113.15
0.35%
Market Trading Hours* (UTC) Opens on Thursday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.50
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.017952 %
Charges from full value of position ($-3.41)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.017952%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.004271 %
Charges from full value of position ($-0.81)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.004271%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency EUR
Margin 5.00%
Stock exchange France
Commission on trade 0%

Key Stats
Prev. Close 112.75
Open 112.25
1-Year Change 12.25%
Day's Range 111.95 - 113.65
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 22, 2025 112.75 -0.80 -0.70% 113.55 114.05 111.85
Apr 17, 2025 113.75 -2.10 -1.81% 115.85 116.65 109.15
Apr 16, 2025 117.95 -0.60 -0.51% 118.55 118.55 116.15
Apr 15, 2025 117.75 2.10 1.82% 115.65 117.95 115.25
Apr 14, 2025 114.35 -0.80 -0.69% 115.15 115.35 113.35
Apr 11, 2025 113.55 2.90 2.62% 110.65 114.45 109.35
Apr 10, 2025 110.25 -4.30 -3.75% 114.55 114.85 109.35
Apr 9, 2025 111.25 -0.50 -0.45% 111.75 113.75 110.75
Apr 8, 2025 115.15 5.40 4.92% 109.75 116.05 109.45
Apr 7, 2025 111.85 8.40 8.12% 103.45 115.65 103.45
Apr 4, 2025 114.35 -3.80 -3.22% 118.15 119.05 113.75
Apr 3, 2025 118.85 2.90 2.50% 115.95 119.85 114.95
Apr 2, 2025 116.55 1.40 1.22% 115.15 116.55 113.95
Apr 1, 2025 115.35 1.20 1.05% 114.15 115.45 114.15
Mar 31, 2025 113.65 -0.90 -0.79% 114.55 115.85 113.45
Mar 28, 2025 115.95 0.80 0.69% 115.15 117.45 114.65
Mar 27, 2025 117.05 1.10 0.95% 115.95 117.65 115.25
Mar 26, 2025 116.55 -0.70 -0.60% 117.25 117.95 115.95
Mar 25, 2025 117.65 0.70 0.60% 116.95 118.35 116.75
Mar 24, 2025 116.75 0.40 0.34% 116.35 117.45 115.95

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Biomerieux Company profile

About BioMerieux SA

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, BioMerieux SA revenues increased 8% to EUR3.38B. Net income applicable to common stockholders increased 49% to EUR601.1M. Revenues reflect Microbiology segment increase of 12% to EUR1.06B, Molecular Biology segment increase of 5% to EUR1.27B, Europe & Middle East & Africa (EMEA) (Region) segment increase of 10% to EUR1.12B, America segment increase of 5% to EUR1.67B.

Equity composition

9/2017, 3-for-1 stock split (Factor: 3).

Industry: Laboratory Diagnostic & Testing Substances

376, chemin de l'Orme
CRAPONNE
AUVERGNE-RHONE-ALPES 69280
FR

People also watch

XRP/USD

2.24 Price
+3.770% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01118

ETH/USD

1,800.04 Price
+6.110% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

BTC/USD

93,868.95 Price
+3.030% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

US100

18,774.80 Price
+2.910% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 720,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading